CFTR and asthma: Epidemiological data suggest that heterozygote carriers of CFTR mutations (who do not have CF) have an increased prevalence of asthma [33] and chronic rhinosinusitis [34] compared to the general population, and there is a higher prevalence of CFTR missense mutations in people with asthma than in the general population [35].